Ocugen
0 sources
Financials
0001628280-26-014435Ocugen
Summary
Ocugen is a business[1].
Key Facts
- Ocugen is in the country of US[2].
- Ocugen's instance of is recorded as business[3].
- Ocugen's instance of is recorded as public company[4].
- Ocugen's headquarters location is recorded as Malvern[5].
- Ocugen's stock exchange is recorded as Nasdaq[6].
- Ocugen's industry is recorded as pharmaceutical industry[7].
- Ocugen's official website is recorded as http://ocugen.com/[8].
- Ocugen's legal form is recorded as XTIQ[9].
- Ocugen's social media followers is recorded as {'amount': '+18385'}[10].
- Ocugen's social media followers is recorded as {'amount': '+31423'}[11].
- Ocugen's social media followers is recorded as {'amount': '+41497'}[12].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300JVNUI9CXWJLR09[13]
-
Registered legal name: Ocugen, INC.[14]
-
Legal jurisdiction: US-DE[15]
-
GLEIF entity category: GENERAL[16]
-
Legal form (ISO 20275 ELF): XTIQ[17]
-
Entity status: ACTIVE[18]
-
LEI registration status: LAPSED[19]
-
LEI first registered: 2014-05-02[20]
-
LEI last updated: 2023-08-04[21]
-
LEI next renewal: 2016-06-25[22]
-
Managing LOU: 5493001KJTIIGC8Y1R12[23]
-
Registration authority: RA000602[24]
-
Authority entity ID: 4190350[25]
-
Other names: Histogenics Corporation[26]
-
Conformity flag: NON_CONFORMING[27]
Body
Operations
Ocugen's headquarters location is recorded as Malvern[5].
Industry
Ocugen's industry is recorded as pharmaceutical industry[7].
Ownership
Ocugen's stock exchange is recorded as Nasdaq[6].